{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T03:18:25Z","timestamp":1792552705820,"version":"4.5.0"},"reference-count":34,"publisher":"American Academy of Pediatrics (AAP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,9,1]]},"abstract":"<jats:p>Objective. The introduction of heptavalent conjugate pneumococcal vaccine (PCV7) has raised concerns for replacement with nonvaccine serotypes in both invasive disease and asymptomatic carriage. Analysis of colonizing serotypes among healthy children in the community provides critical data on such changes.<\/jats:p>\n               <jats:p>Methods. Nasopharyngeal specimens were obtained from children who were younger than 7 years during well-child or sick visits in primary care practices in 16 Massachusetts communities during 2001 and 2004. Susceptibility testing and serotyping were performed on isolated Streptococcus pneumoniae strains. Vaccination history with PCV7 was abstracted from the medical record.<\/jats:p>\n               <jats:p>Results. Among colonizing pneumococcal isolates, PCV7 serotypes decreased from 36% to 14%, and non-PCV7 serotypes increased from 34% to 55%. Overall carriage did not change (26% to 23%); neither did carriage of potentially cross-reactive serotypes (30% to 31%). The most common non-PCV7 serotypes were serotypes 11, 15, and 29. There was a substantial increase in penicillin nonsusceptibility from 8% to 25% in non-PCV7 serotypes; 35% were highly resistant to penicillin. Penicillin nonsusceptibility increased from 45% to 56% among PCV7 serotypes while remaining stable among PCV7 potentially cross-reactive strains (51% vs 54%).<\/jats:p>\n               <jats:p>Conclusions. Pneumococcal colonization has changed after the introduction of PCV7, both in serotype distribution and in patterns of antibiotic resistance. The frequency of nonvaccine strains has increased, and the proportion of nonvaccine isolates that are not susceptible to penicillin has tripled. This shift toward increased carriage of nonvaccine serotypes warrants vigilance for changes in the epidemiology of invasive pneumococcal disease.<\/jats:p>","DOI":"10.1542\/peds.2004-2338","type":"journal-article","created":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:36:02Z","timestamp":1125534962000},"page":"e408-e413","source":"Crossref","is-referenced-by-count":269,"title":["Post-PCV7 Changes in Colonizing Pneumococcal Serotypes in 16 Massachusetts Communities, 2001 and 2004"],"prefix":"10.1542","volume":"116","author":[{"given":"Susan S.","family":"Huang","sequence":"first","affiliation":[{"name":"Channing Laboratory, Brigham and Women's Hospital, Boston, Massachusetts"},{"name":"Department of Ambulatory Care and Prevention, Harvard Medical School and Harvard Pilgrim Health Care, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Platt","sequence":"additional","affiliation":[{"name":"Channing Laboratory, Brigham and Women's Hospital, Boston, Massachusetts"},{"name":"Department of Ambulatory Care and Prevention, Harvard Medical School and Harvard Pilgrim Health Care, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheryl L.","family":"Rifas-Shiman","sequence":"additional","affiliation":[{"name":"Department of Ambulatory Care and Prevention, Harvard Medical School and Harvard Pilgrim Health Care, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen I.","family":"Pelton","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Boston University School of Medicine, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald","family":"Goldmann","sequence":"additional","affiliation":[{"name":"Divisions of Infectious Diseases"},{"name":"Department of Pediatrics, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan A.","family":"Finkelstein","sequence":"additional","affiliation":[{"name":"Department of Ambulatory Care and Prevention, Harvard Medical School and Harvard Pilgrim Health Care, Boston, Massachusetts"},{"name":"Department of Pediatrics, Harvard Medical School, Boston, Massachusetts"},{"name":"General Pediatrics, Children's Hospital Boston, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2005,9,1]]},"reference":[{"key":"2021120820033043100_R1","doi-asserted-by":"crossref","unstructured":"Robinson KA, Baughman W, Rothrock G, et al. Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995\u20138: opportunities for prevention in the conjugate vaccine era. JAMA.\u20082001;285:1729\u20131735","DOI":"10.1001\/jama.285.13.1729"},{"key":"2021120820033043100_R2","doi-asserted-by":"crossref","unstructured":"Schwartz B, Bell DM, Hughes JM. Preventing the emergence of antimicrobial resistance. A call to action by clinicians, public health officials, and patients. JAMA.\u20081997;278:944\u2013945","DOI":"10.1001\/jama.278.11.944"},{"key":"2021120820033043100_R3","doi-asserted-by":"crossref","unstructured":"Jernigan DB, Cetron MS, Breiman RF. Minimizing the impact of drug-resistant Streptococcus pneumoniae (DRSP): a strategy from the DRSP working group. JAMA.\u20081996;275:206\u2013209","DOI":"10.1001\/jama.275.3.206"},{"key":"2021120820033043100_R4","unstructured":"Whitney CG, Farley MM, Hadler J, et al; Active Bacterial Core Surveillance of the Emerging Infections Program Network. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med.\u20082003;348:1737\u20131746"},{"key":"2021120820033043100_R5","doi-asserted-by":"crossref","unstructured":"Arnold KE, Leggiadro RJ, Breiman RF, et al. Risk factors for carriage of drug-resistant Streptococcus pneumoniae among children in Memphis, Tennessee. J Pediatr.\u20081996;128:757\u2013764","DOI":"10.1016\/S0022-3476(96)70326-8"},{"key":"2021120820033043100_R6","doi-asserted-by":"crossref","unstructured":"Duchin JS, Breiman RF, Diamond A, et al. High prevalence of multidrug-resistant Streptococcus pneumoniae among children in a rural Kentucky community. Pediatr Infect Dis J.\u20081995;14:745\u2013750","DOI":"10.1097\/00006454-199509000-00004"},{"key":"2021120820033043100_R7","doi-asserted-by":"crossref","unstructured":"Boken DJ, Chartrand SA, Moland ES, Goering RV. Colonization with penicillin-nonsusceptible Streptococcus pneumoniae in urban and rural child-care centers. Pediatr Infect Dis J.\u20081996;15:667\u2013672","DOI":"10.1097\/00006454-199608000-00006"},{"key":"2021120820033043100_R8","doi-asserted-by":"crossref","unstructured":"Zangwill KM, Vadheim CM, Vannier AM, Hemenway LS, Greenberg DP, Ward JI. Epidemiology of invasive pneumococcal disease in southern California: implications for the design and conduct of a pneumococcal conjugate vaccine efficacy trial. J Infect Dis.\u20081996;174:752\u2013759","DOI":"10.1093\/infdis\/174.4.752"},{"key":"2021120820033043100_R9","doi-asserted-by":"crossref","unstructured":"Whitney CG, Farley MM, Hadler J, et al; Active Bacterial Core Surveillance Program of the Emerging Infections Program Network. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N Engl J Med.\u20082000;343:1917\u20131924","DOI":"10.1056\/NEJM200012283432603"},{"key":"2021120820033043100_R10","unstructured":"Black S, Shinefield H, Fireman B, et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J.\u20082000;19:187\u2013195"},{"key":"2021120820033043100_R11","doi-asserted-by":"crossref","unstructured":"Black SB, Shinefield HR, Ling S, et al. Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia. Pediatr Infect Dis J.\u20082002;21:810\u2013815","DOI":"10.1097\/00006454-200209000-00005"},{"key":"2021120820033043100_R12","doi-asserted-by":"crossref","unstructured":"Black S, Shinefield H, Baxter R, et al. Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente. Pediatr Infect Dis J.\u20082004;23:485\u2013489","DOI":"10.1097\/01.inf.0000129685.04847.94"},{"key":"2021120820033043100_R13","doi-asserted-by":"crossref","unstructured":"Dagan R, Melamed R, Muallem M, et al. Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine. J Infect Dis.\u20081996;174:1271\u20131278","DOI":"10.1093\/infdis\/174.6.1271"},{"key":"2021120820033043100_R14","doi-asserted-by":"crossref","unstructured":"Mbelle N, Huebner RE, Wasas AD, Kimura A, Chang I, Klugman KP. Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine. J Infect Dis.\u20081999;180:1171\u20131176","DOI":"10.1086\/315009"},{"key":"2021120820033043100_R15","doi-asserted-by":"crossref","unstructured":"Dagan R, Givon-Lavi N, Zamir O, Fraser D. Effect of a nonavalent conjugate vaccine on carriage of antibiotic-resistant Streptococcus pneumoniae in day-care centers. Pediatr Infect Dis J.\u20082003;22:532\u2013540","DOI":"10.1097\/01.inf.0000069761.11093.c3"},{"key":"2021120820033043100_R16","doi-asserted-by":"crossref","unstructured":"Spratt BG, Greenwood BM. Prevention of pneumococcal disease by vaccination: does serotype replacement matter?Lancet.\u20082000;356:1210\u20131211","DOI":"10.1016\/S0140-6736(00)02779-3"},{"key":"2021120820033043100_R17","doi-asserted-by":"crossref","unstructured":"Pelton SI, Klein JO. The future of pneumococcal conjugate vaccines for prevention of pneumococcal diseases in infants and children. Pediatrics.\u20082002;110:805\u2013814","DOI":"10.1542\/peds.110.4.805"},{"key":"2021120820033043100_R18","doi-asserted-by":"crossref","unstructured":"Brueggemann AB, Griffiths DT, Meats E, Peto T, Crook DW, Spratt BG. Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential. J Infect Dis.\u20082003;187:1424\u20131432","DOI":"10.1086\/374624"},{"key":"2021120820033043100_R19","doi-asserted-by":"crossref","unstructured":"Hanage WP, Kaijalainen TH, Syrjanen RK, et al. Invasiveness of serotypes and clones of Streptococcus pneumoniae among children in Finland. Infect Immun.\u20082005;73:431\u2013435","DOI":"10.1128\/IAI.73.1.431-435.2005"},{"key":"2021120820033043100_R20","doi-asserted-by":"crossref","unstructured":"Finkelstein JA, Huang SS, Daniel J, et al. Antibiotic-resistant Streptococcus pneumoniae in the heptavalent pneumococcal conjugate vaccine era: predictors of carriage in a multicommunity sample. Pediatrics.\u20082003;112:862\u2013869","DOI":"10.1542\/peds.112.4.862"},{"key":"2021120820033043100_R21","unstructured":"National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptibility Testing; Fourteenth Informational Supplement. NCCLS document M100-S14. Wayne, PA: NCCLS; 2004"},{"key":"2021120820033043100_R22","unstructured":"Centers for Disease Control and Prevention (CDC). Effect of new susceptibility breakpoints on reporting of resistance in Streptococcus pneumoniae\u2013United States, 2003. MMWR Morb Mortal Wkly Rep.\u20082004;53:152\u2013154"},{"key":"2021120820033043100_R23","doi-asserted-by":"crossref","unstructured":"Konradsen HB; Pneumococcus Reference Laboratories in Europe. Validation of serotyping of Streptococcus pneumoniae in Europe. Vaccine.\u20082005;23:1368\u20131373","DOI":"10.1016\/j.vaccine.2004.09.011"},{"key":"2021120820033043100_R24","doi-asserted-by":"crossref","unstructured":"Meats E, Brueggemann AB, Enright MC, et al. Stability of serotypes during nasopharyngeal carriage of Streptococcus pneumoniae.J Clin Microbiol.\u20082003;41:386\u2013392","DOI":"10.1128\/JCM.41.1.386-392.2003"},{"key":"2021120820033043100_R25","doi-asserted-by":"crossref","unstructured":"Gherardi G, Whitney CG, Facklam RR, Beall B. Major related sets of antibiotic-resistant Pneumococci in the United States as determined by pulsed-field gel electrophoresis and pbp1a-pbp2b-pbp2x-dhf restriction profiles. J Infect Dis.\u20082000;181:216\u2013229","DOI":"10.1086\/315194"},{"key":"2021120820033043100_R26","doi-asserted-by":"crossref","unstructured":"van Selm S, van Cann LM, Kolkman MA, van der Zeijst BA, van Putten JP. Genetic basis for the structural difference between Streptococcus pneumoniae serotype 15B and 15C capsular polysaccharides. Infect Immun.\u20082003;71:6192\u20136198","DOI":"10.1128\/IAI.71.11.6192-6198.2003"},{"key":"2021120820033043100_R27","doi-asserted-by":"crossref","unstructured":"Ramirez M, Tomasz A. Acquisition of new capsular genes among clinical isolates of antibiotic-resistant Streptococcus pneumoniae.Microb Drug Resist.\u20081999;5:241\u2013246","DOI":"10.1089\/mdr.1999.5.241"},{"key":"2021120820033043100_R28","doi-asserted-by":"crossref","unstructured":"Porat N, Arguedas A, Spratt BG, et al. Emergence of penicillin-nonsusceptible Streptococcus pneumoniae clones expressing serotypes not present in the antipneumococcal conjugate vaccine. J Infect Dis.\u20082004;190:2154\u20132161","DOI":"10.1086\/425908"},{"key":"2021120820033043100_R29","doi-asserted-by":"crossref","unstructured":"McCormick AW, Whitney CG, Farley MM, et al. Geographic diversity and temporal trends of antimicrobial resistance in Streptococcus pneumoniae in the United States. Nat Med.\u20082003;9:424\u2013430","DOI":"10.1038\/nm839"},{"key":"2021120820033043100_R30","unstructured":"Widdowson CA, Klugman KP. Molecular mechanisms of resistance to commonly used non-betalactam drugs in Streptococcus pneumoniae.Semin Respir Infect.\u20081999;14:255\u2013268"},{"key":"2021120820033043100_R31","unstructured":"Centers for Disease Control and Prevention (CDC). National, state, and urban area vaccination coverage among children aged 19\u201335 months United States, 2003. MMWR Morb Mortal Wkly Rep.\u20082004;53:658\u2013661"},{"key":"2021120820033043100_R32","doi-asserted-by":"crossref","unstructured":"Kaplan SL, Mason EO Jr, Wald ER, et al. Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine. Pediatrics.\u20082004;113:443\u2013449","DOI":"10.1542\/peds.113.3.443"},{"key":"2021120820033043100_R33","doi-asserted-by":"crossref","unstructured":"Gertz RE Jr, McEllistrem MC, Boxrud DJ, et al. Clonal distribution of invasive pneumococcal isolates from children and selected adults in the United States prior to 7-valent conjugate vaccine introduction. J Clin Microbiol.\u20082003;41:4194\u20134216","DOI":"10.1128\/JCM.41.9.4194-4216.2003"},{"key":"2021120820033043100_R34","doi-asserted-by":"crossref","unstructured":"Porat N, Barkai G, Jacobs MR, Trefler R, Dagan R. Four antibiotic-resistant Streptococcus pneumoniae clones unrelated to the pneumococcal conjugate vaccine serotypes, including 2 new serotypes, causing acute otitis media in southern Israel. J Infect Dis.\u20082004;189:385\u2013392","DOI":"10.1086\/381183"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/116\/3\/e408\/1005200\/zpe0090500e408.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/116\/3\/e408\/1005200\/zpe0090500e408.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T23:28:07Z","timestamp":1639006087000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/116\/3\/e408\/68398\/Post-PCV7-Changes-in-Colonizing-Pneumococcal"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9,1]]},"references-count":34,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2005,9,1]]},"published-print":{"date-parts":[[2005,9,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2004-2338","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,9,1]]}}}